0000899243-21-012381.txt : 20210317 0000899243-21-012381.hdr.sgml : 20210317 20210317213526 ACCESSION NUMBER: 0000899243-21-012381 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nussbaum Robert L CENTRAL INDEX KEY: 0001640322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 21752806 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-12 0 0001501134 Invitae Corp NVTA 0001640322 Nussbaum Robert L C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Medical Officer Common Stock 2021-03-12 4 A 0 24936 0.00 A 250248 D Common Stock 2021-03-12 4 S 0 11894 42.9006 D 238354 D Common Stock 2021-03-12 4 S 0 6265 42.9006 D 232089 D Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2022, subject to continued service with the Issuer through such vesting date. Includes an aggregate of 100,817 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold. /s/ Thomas Brida, Attorney-in-Fact 2021-03-17